Interferon-α induces G1 cell-cycle arrest in renal cell carcinoma cells via activation of jak-stat signaling

Cancer Investigation

Volumn 29, Issue 5, 2011, Pages 347-352

  Shang, Donghao ^a   Yang, Peiqian ^a   Liu, Yuting ^b   Song, Jian ^a   Zhang, Fengbo ^a   Tian, Ye ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Renal cell carcinoma

Indexed keywords

ALPHA INTERFERON; JANUS KINASE; STAT1 PROTEIN;

APOPTOSIS; ARTICLE; CANCER INHIBITION; CANCER RESISTANCE; CARCINOMA CELL; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CONTROLLED STUDY; FLOW CYTOMETRY; IN VITRO STUDY; KIDNEY CARCINOMA; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TARGETING; WESTERN BLOTTING;

ANTINEOPLASTIC AGENTS; APOPTOSIS; BLOTTING, WESTERN; CARCINOMA, RENAL CELL; CASPASES; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; DRUG RESISTANCE, NEOPLASM; ENZYME ACTIVATION; FLOW CYTOMETRY; HUMANS; INTERFERON ALFA-2B; JANUS KINASES; KIDNEY NEOPLASMS; PHOSPHORYLATION; PROLIFERATING CELL NUCLEAR ANTIGEN; SIGNAL TRANSDUCTION; STAT1 TRANSCRIPTION FACTOR; TRANSFECTION;

EID: 79957508249     PISSN: 07357907     EISSN: 15324192     Source Type: Journal    
DOI: 10.3109/07357907.2011.568566     Document Type: Article

References (20)

1. Pantuck AJ, Zisman A, Belldegrun AS.The changing natural history of renal cell carcinoma. J Urol 2001;166: 1611-1623
2. Hartmann JT, Bokemeyer C. Chemotherapy for renal cell carcinoma. Anticancer Res 1999;19: 1541-1543 (Pubitemid 29255643)
3. Hernberg M, Pyrhonen S,Muhonen T. Regimens with or without interferon-alpha as treatment for metastatic melanoma and renal cell carcinoma: an overview of randomized trials. J Immunother 1999;22: 145-154 (Pubitemid 29135899)
4. Yanai Y, Horie S, Yamamoto K, Yamauchi H, et al. Characterization of the antitumor activities of IFN-alpha8 on renal cell carcinoma cells in vitro. J Interferon Cytokine Res 1999;21: 1129-1136
5. Darnell JE, Kerr IM, Stark GR. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 1994;264: 1415-1421 (Pubitemid 24217131)
6. Stebbing J, Gore M. The current status of interferon-alpha treatment in advanced renal cancer. BJU Int 2001;87: 599-601 (Pubitemid 34293747)
7. Verra N, de Jong D, Bex A, et al. Infiltration of activated dendritic cells and T cells in renal cell carcinoma following combined cytokine immunotherapy. Eur Urol 2005;48: 527-533 (Pubitemid 41188416)
8. Kawai S,Azuma Y, Fujii E, et al. Interferon-alpha enhances CD317 expression and the antitumor activity of anti-CD317 monoclonal antibody in renal cell carcinoma xenograft models. Cancer Sci 2008;99: 2461-2466
9. Chawla-Sarkar M, Leaman DW, Borden EC. Preferential induction of apoptosis by interferon (IFN)-beta compared with IFNalpha2: correlation with TRAIL/Apo2L induction in melanoma cell lines. Clin Cancer Res 2001;7: 1821-1831 (Pubitemid 32708654)
10. Ossina NK, CannasA, PowersVC, et al. Interferon-gammamodulates a p53-independent apoptotic pathway and apoptosis-related gene expression. J Biol Chem 1997;272: 16351-16357 (Pubitemid 27276459)
11. Thyrell L, Erickson S, Zhivotovsky B, et al. Mechanisms of Interferon-alpha induced apoptosis in malignant cells. Oncogene 2002;21: 1251-1262 (Pubitemid 34185242)
12. Pfeffer LM, Wang C, Constantinescu SN, et al. Human renal cancers resistant to IFN's antiproliferative action exhibit sensitivity to IFN's gene-inducing and antiviral actions. J Urol 1996;156: 1867-1871 (Pubitemid 26344072)
13. Schick N, Oakeley EJ, Hynes NE, Badache A. TEL/ETV6 is a signal transducer and activator of transcription 3 (Stat3)- induced repressor of Stat3 activity. J Biol Chem 2004;279: 38787-38796 (Pubitemid 39296037)
14. Hirano T, Ishihara K, Hibi M. Roles of STAT3 in mediating the cell growth, differentiation and survival signals relayed through the IL-6 family of cytokine receptors. Oncogene 2000;19: 2548-2556 (Pubitemid 30339210)
15. Barton BE, Karras JG, Murphy TF, Barton A, Huang HF. Signal transducer and activator of transcription 3 (STAT3) activation in prostate cancer: direct STAT3 inhibition induces apoptosis in prostate cancer lines. Mol CancerTher 2004;3: 11-20 (Pubitemid 39193674)
16. Shang D, Liu Y, Ito N, Kamoto T, Ogawa O. Defective Jak-Stat activation in renal cell carcinoma is associated with interferonalpha resistance. Cancer Sci 2007;98: 1259-1264 (Pubitemid 46993547)
17. Vlotides G, Sörensen AS, Kopp F, et al. SOCS-1 and SOCS-3 inhibit IFN-α-induced expression of the antiviral proteins 2, 5- OAS and MxA. Biochem Biophys Res Commun 2004;320: 1007-1014 (Pubitemid 38887243)
18. Shen X, Hong F, Nguyen VA, Gao B. IL-10 attenuates IFN-α- activated STAT1 in the liver: involvement of SOCS2 and SOCS3 FEBS Lett 2000;480: 132-136
19. Zhu H, Nelson DR, Crawford JM, Liu C. Defective Jak-Stat activation in hepatoma cells is associated with hepatitis C viral IFN-α resistance. J Interferon Cytokine Res 2005;25: 528-539 (Pubitemid 41395840)
20. Shimazui T, Ami Y, Yoshikawa K, et al. Prediction of in vitro response to interferon-alpha in renal cell carcinoma cell lines. Cancer Sci 2007;98: 529-534 (Pubitemid 46562743)